Beneficient Class A Common Stock (BENF)
Official siteFINANCIAL SERVICES • ASSET MANAGEMENT • NASDAQ
Market Cap: $9.74M
Last updated: Nov 17, 2026 at 10:58 AM ET
Beneficient Class A Common Stock (BENF) Financials: Revenue, Profit and Cash Flow
Beneficient Class A Common Stock reported revenue of -$39.13M for the fiscal year ended Mar 31, 2026. That year, net income was -$87.43M, operating cash flow was -$38.72M and free cash flow was -$38.81M. The quarter ended Jun 30, 2026 had revenue of $12.16M and net income of -$6.78M.
Revenue and Margins
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Mar 2026 | -$39.13M | N/A | N/A | N/A | N/A |
| Mar 2025 | -$7.95M | N/A | N/A | N/A | N/A |
| Mar 2024 | -$98.91M | N/A | N/A | N/A | N/A |
| Mar 2023 | -$104.99M | -319.1% | N/A | N/A | N/A |
| Mar 2022 | $47.91M | -53.0% | -1.3% | -148.4% | -198.3% |
| Mar 2021 | $101.98M | +69.1% | 79.6% | -46.5% | -56.9% |
| Mar 2020 | $60.29M | -24.1% | 100.0% | -224.5% | -554.0% |
| Mar 2019 | $79.47M | +96.6% | 95.4% | 52.1% | -6.3% |
| Mar 2018 | $40.43M | N/A | 81.4% | 61.2% | -22.3% |
Income Statement
In the fiscal year ended Mar 2026, the company posted a net loss after a profit the year before. In the quarter ended Jun 2026, the net loss widened from the same quarter a year earlier.
Annual
| Line item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | -$39.13M | -$7.95M | -$98.91M | -$104.99M | $47.91M | $101.98M | $60.29M | $79.47M | $40.43M |
| Cost of revenue | $1.49M | $16.85M | $65.13M | $45.53M | $48.52M | $20.78M | N/A | $3.67M | $7.54M |
| Gross profit | -$859.00K | -$24.80M | -$164.04M | -$150.52M | -$612.00K | $81.20M | $60.29M | $75.80M | $32.89M |
| Research and development | $0 | $0 | $0 | $0 | $0 | $0 | $1.21M | $0 | $0 |
| Operating income | -$79.78M | -$24.18M | -$2.65B | -$253.17M | -$71.12M | -$47.41M | -$135.38M | $41.44M | $24.73M |
| Net income | -$87.43M | $51.16M | -$2.10B | -$130.98M | -$95.02M | -$58.04M | -$334.04M | -$5.01M | -$9.00M |
| EBITDA | N/A | N/A | -$2.64B | -$234.09M | -$41.67M | -$13.81M | -$135.05M | $41.68M | $27.76M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.16M | $49.00K | $198.00K | -$2.76M | -$30.97M | -$30.97M | $4.42M | $8.56M | $10.05M | -$43.10M | -$10.30M | -$42.76M |
| Gross profit | $9.34M | -$393.00K | $11.71M | -$2.76M | -$30.97M | -$33.91M | $4.42M | $1.43M | $6.20M | -$49.67M | -$17.64M | -$58.16M |
| Operating income | $4.19M | -$52.17M | $11.75M | -$17.86M | -$45.30M | -$42.23M | -$9.51M | -$13.71M | $44.34M | -$67.79M | -$915.95M | -$381.76M |
| Net income | -$6.78M | -$38.63M | $19.91M | -$3.63M | -$780.00K | -$780.00K | -$8.64M | $12.91M | $47.67M | -$66.22M | -$542.17M | -$371.74M |
Balance Sheet
As of Mar 2026, long-term debt of $96.78M exceeded cash and equivalents by $94.24M. Shareholder equity was negative, at -$214.02M, as total liabilities of $337.53M exceeded total assets of $238.77M.
Annual
| Line item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $238.77M | $354.88M | $368.50M | $368.50M | $2.91B | $3.14B | $2.82B | $2.68B | $2.08B |
| Current assets | $2.54M | $46.57M | $17.80M | $17.80M | $28.27M | $84.97M | $28.01M | $279.06M | $41.10M |
| Cash and equivalents | $2.54M | $1.35M | $7.91M | $7.91M | $8.73M | $70.59M | $12.49M | $17.55M | $3.54M |
| Total liabilities | $337.53M | $299.27M | $309.57M | $309.57M | $231.79M | $241.43M | $282.84M | $441.08M | $690.86M |
| Short-term debt | N/A | N/A | $120.50M | $151.44M | N/A | N/A | N/A | $576.00K | N/A |
| Long-term debt | $96.78M | $117.90M | $120.50M | $52.13M | $65.67M | $180.08M | N/A | N/A | N/A |
| Shareholder equity | -$214.02M | -$167.00M | -$234.35M | -$234.35M | $2.68B | $1.44B | $621.50M | $563.97M | $320.46M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $250.94M | $238.77M | $337.86M | $316.23M | $354.88M | $354.88M | $400.01M | $368.79M | $361.30M | $368.50M | $368.79M | $361.30M |
| Total liabilities | $344.50M | $337.53M | $375.90M | $368.53M | $299.27M | $299.27M | $295.23M | $256.45M | $258.54M | $309.57M | $256.45M | $258.54M |
| Cash and equivalents | $5.58M | $2.54M | $7.87M | $4.90M | $1.35M | $1.35M | $4.15M | $4.48M | $4.40M | $7.91M | $4.48M | $4.40M |
| Shareholder equity | -$210.40M | -$214.02M | -$179.73M | -$222.89M | -$167.00M | -$167.00M | -$166.64M | -$165.30M | -$182.58M | -$234.35M | -$165.30M | -$182.58M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Mar 2026.
Annual
| Line item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$38.72M | -$37.70M | -$58.22M | -$95.12M | -$57.00M | -$54.01M | -$51.19M | $17.81M | -$2.08M |
| Capital expenditures | $96.00K | $1.10M | $1.76M | $2.08M | $4.20M | $3.22M | $2.98M | $374.00K | $196.14K |
| Free cash flow | -$38.81M | -$38.80M | -$59.98M | -$97.19M | -$61.21M | -$57.23M | -$54.17M | $17.44M | -$2.28M |
| Dividends paid | N/A | N/A | N/A | $6.12M | N/A | N/A | N/A | N/A | N/A |
| Investing cash flow | $61.21M | $28.11M | $44.06M | $63.02M | $44.59M | -$5.98M | $70.44M | $141.54M | $102.43K |
| Financing cash flow | -$21.29M | $2.97M | $12.59M | -$34.46M | $14.86M | $43.86M | -$5.24M | -$156.36M | -$5.34M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$4.11M | -$38.72M | -$9.37M | -$14.53M | -$8.45M | -$8.45M | -$10.00M | -$8.61M | -$10.65M | -$8.65M | -$22.21M | -$13.45M |
| Capital expenditures | $0 | $96.00K | $173.00K | $269.00K | $124.00K | $124.00K | $42.00K | $269.00K | $664.00K | $429.00K | $375.00K | $432.00K |
| Free cash flow | -$4.11M | -$38.81M | -$9.55M | -$14.80M | -$8.57M | -$8.57M | -$10.04M | -$8.88M | -$11.31M | -$9.07M | -$22.59M | -$13.88M |
Frequently Asked Questions About BENF
What is Beneficient Class A Common Stock's annual revenue?
Beneficient Class A Common Stock reported revenue of -$39.13M for the fiscal year ended Mar 31, 2026.
Is Beneficient Class A Common Stock profitable?
No. Beneficient Class A Common Stock reported net income of -$87.43M for the fiscal year ended Mar 31, 2026.
How much free cash flow does BENF generate?
For the fiscal year ended Mar 31, 2026, operating cash flow of -$38.72M minus capital expenditures of $96.00K produced free cash flow of -$38.81M.
How much debt does Beneficient Class A Common Stock have?
The balance sheet dated Mar 31, 2026 reported long-term debt of $96.78M and cash and equivalents of $2.54M.
BENF pages: Overview, Forecast, Financials, Competitors